JPWO2020239999A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020239999A5
JPWO2020239999A5 JP2021570919A JP2021570919A JPWO2020239999A5 JP WO2020239999 A5 JPWO2020239999 A5 JP WO2020239999A5 JP 2021570919 A JP2021570919 A JP 2021570919A JP 2021570919 A JP2021570919 A JP 2021570919A JP WO2020239999 A5 JPWO2020239999 A5 JP WO2020239999A5
Authority
JP
Japan
Prior art keywords
phenyl
ethynyl
pyrimidin
hydroxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021570919A
Other languages
English (en)
Japanese (ja)
Other versions
JP7547387B2 (ja
JP2022534302A5 (https=
JP2022534302A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/065024 external-priority patent/WO2020239999A1/en
Publication of JP2022534302A publication Critical patent/JP2022534302A/ja
Publication of JPWO2020239999A5 publication Critical patent/JPWO2020239999A5/ja
Publication of JP2022534302A5 publication Critical patent/JP2022534302A5/ja
Priority to JP2024146717A priority Critical patent/JP2024167319A/ja
Application granted granted Critical
Publication of JP7547387B2 publication Critical patent/JP7547387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021570919A 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤 Active JP7547387B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024146717A JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962855144P 2019-05-31 2019-05-31
US62/855,144 2019-05-31
US201962907833P 2019-09-30 2019-09-30
US62/907,833 2019-09-30
PCT/EP2020/065024 WO2020239999A1 (en) 2019-05-31 2020-05-29 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024146717A Division JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Publications (4)

Publication Number Publication Date
JP2022534302A JP2022534302A (ja) 2022-07-28
JPWO2020239999A5 true JPWO2020239999A5 (https=) 2023-06-05
JP2022534302A5 JP2022534302A5 (https=) 2023-06-05
JP7547387B2 JP7547387B2 (ja) 2024-09-09

Family

ID=71108552

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570919A Active JP7547387B2 (ja) 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤
JP2024146717A Pending JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024146717A Pending JP2024167319A (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Country Status (37)

Country Link
US (3) US11254673B2 (https=)
EP (2) EP3976597B1 (https=)
JP (2) JP7547387B2 (https=)
KR (1) KR20220027871A (https=)
CN (2) CN114222737B (https=)
AU (1) AU2020282005B2 (https=)
BR (1) BR112021023796A2 (https=)
CL (1) CL2021003142A1 (https=)
CO (1) CO2021017838A2 (https=)
CR (1) CR20210587A (https=)
DK (1) DK3976597T3 (https=)
DO (1) DOP2021000244A (https=)
EC (1) ECSP21093623A (https=)
ES (1) ES2989387T3 (https=)
FI (1) FI3976597T3 (https=)
HR (1) HRP20241352T1 (https=)
HU (1) HUE068694T2 (https=)
IL (1) IL288387B2 (https=)
JO (1) JOP20210318B1 (https=)
LT (1) LT3976597T (https=)
MA (1) MA56038B1 (https=)
MD (1) MD3976597T2 (https=)
MX (1) MX2021014679A (https=)
MY (1) MY205653A (https=)
PE (1) PE20220768A1 (https=)
PH (1) PH12021553011A1 (https=)
PL (1) PL3976597T3 (https=)
PT (1) PT3976597T (https=)
RS (1) RS66105B1 (https=)
SA (1) SA521430960B1 (https=)
SG (1) SG11202112994WA (https=)
SI (1) SI3976597T1 (https=)
SM (1) SMT202400418T1 (https=)
TW (2) TWI850390B (https=)
UA (1) UA130430C2 (https=)
UY (1) UY38721A (https=)
WO (1) WO2020239999A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114222737B (zh) * 2019-05-31 2024-07-26 詹森药业有限公司 NF-κB诱导激酶的小分子抑制剂
WO2020243423A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
KR20220030222A (ko) 2019-05-31 2022-03-10 이케나 온콜로지, 인코포레이티드 Tead 억제제 및 이의 용도
IL316886A (en) * 2022-05-11 2025-01-01 Janssen Pharmaceutica Nv History of pyrrolidinones as NF kappa B kinase inhibitors
CA3257152A1 (en) * 2022-05-11 2023-11-16 Janssen Pharmaceutica Nv Pyrrolidine derivatives useful as NF-κB induction kinase inhibitors
EP4637773A1 (en) 2022-12-22 2025-10-29 Boehringer Ingelheim International GmbH Crystalline forms of a her2 inhibitor
WO2025020886A1 (zh) * 2023-07-27 2025-01-30 浙江星浩澎博医药有限公司 氮杂喹唑啉环衍生物及其用途
IL326016A (en) 2023-07-28 2026-03-01 Boehringer Ingelheim Int Process for manufacturing a HER2 inhibitor
WO2025235874A1 (en) * 2024-05-10 2025-11-13 Schrödinger, Inc. Heterocyclics as egfr inhibitors
JP2026022634A (ja) * 2024-07-30 2026-02-12 日本たばこ産業株式会社 ピラゾロピリミジン化合物及びその医薬用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US7132428B2 (en) 2003-07-03 2006-11-07 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
JP2008509138A (ja) * 2004-08-03 2008-03-27 ワイス 心臓血管疾患の治療に有用なインダゾール類
WO2006053277A2 (en) 2004-11-12 2006-05-18 Chippac, Inc. Wire bond interconnection
AU2009263037B2 (en) * 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
MX2013010513A (es) * 2011-03-16 2013-10-07 Hoffmann La Roche Compuestos de alcohol 6,5-heterociclil-propargilico y usos de los mismos.
JP2015507001A (ja) 2012-02-17 2015-03-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 三環式化合物及びその使用方法
US8859553B2 (en) * 2012-07-30 2014-10-14 Astar Biotech Llc Protein kinase inhibitors
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
US20150057260A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Alkynyl alcohols and methods of use
US20160096850A9 (en) * 2013-08-22 2016-04-07 Genentech, Inc. Alkynyl alcohols and methods of use
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
AU2015334917B2 (en) 2014-10-23 2019-08-29 Janssen Pharmaceutica Nv New compounds as NIK inhibitors
BR112017008039B1 (pt) 2014-10-23 2023-04-11 Janssen Pharmaceutica N.V. Derivados de pirazol como inibidores de nik, seu uso no tratamento ou prevenção de câncer e composição farmacêutica que os compreende
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
MX371151B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE TIENOPIRIMIDINA EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
JP2018510140A (ja) 2015-02-25 2018-04-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft アルキニルアルコール及び使用方法
ES2775449T3 (es) 2016-01-22 2020-07-27 Janssen Pharmaceutica Nv Nuevos derivados de cianoindolina sustituida como inhibidores de nik
EP3405464B1 (en) 2016-01-22 2019-12-04 Janssen Pharmaceutica NV New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
ES2837157T3 (es) 2016-06-30 2021-06-29 Janssen Pharmaceutica Nv Derivados de cianoindolina como inhibidores de NIK
WO2018002217A1 (en) 2016-06-30 2018-01-04 Janssen Pharmaceutica Nv Heteroaromatic derivatives as nik inhibitors
WO2018037058A1 (en) * 2016-08-24 2018-03-01 F. Hoffmann-La Roche Ag 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
WO2018037059A1 (en) 2016-08-24 2018-03-01 F. Hoffmann-La Roche Ag 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
CN110831940B (zh) 2017-07-06 2023-06-20 詹森药业有限公司 作为nik抑制剂的新取代的氮杂吲哚啉衍生物
CN109810110B (zh) * 2017-11-22 2023-01-24 中国科学院上海药物研究所 一种具有2-氨基嘧啶结构的化合物,其制备方法和用途
CN114222737B (zh) * 2019-05-31 2024-07-26 詹森药业有限公司 NF-κB诱导激酶的小分子抑制剂
WO2020243423A1 (en) 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)
KR20220030222A (ko) 2019-05-31 2022-03-10 이케나 온콜로지, 인코포레이티드 Tead 억제제 및 이의 용도
BR112021022099A2 (pt) 2019-05-31 2021-12-28 Chiesi Farm Spa Derivados de amino quinazolina como inibidores de p2x3
WO2021067217A1 (en) 2019-09-30 2021-04-08 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators

Similar Documents

Publication Publication Date Title
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
IL310992A (en) NLRP3 inhibitors
US9334274B2 (en) N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
JP2024532733A (ja) 複素環式化合物及び使用方法
TWI766281B (zh) 作為jak1抑制劑之哌啶-4-基三亞甲亞胺衍生物
JP2024517693A (ja) 2-アミノベンゾチアゾール化合物及びその使用方法
US12281122B1 (en) PI3K inhibitors
HRP20240994T1 (hr) Spoj inhibitora jak i njegova uporaba
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP2022500402A5 (https=)
US20110053897A1 (en) Compounds and compositions as syk kinase inhibitors
JP2018529731A5 (https=)
JP2017518326A5 (https=)
JP2020531498A5 (https=)
JP2018044012A (ja) ドライアイおよび他の目に関連する疾患を治療するためのヤヌスキナーゼ阻害剤
JP2016500671A5 (https=)
JP2013508404A5 (https=)
JP2018522859A5 (https=)
JP2019535664A5 (https=)
JP2016537384A5 (https=)
ME02595B (me) Heterociklilamini kao inhibitori pi3k
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
JP2020526549A5 (https=)
RU2008142832A (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта